These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25432390)

  • 1. Lipoprotein(a): an important cardiovascular risk factor and a clinical conundrum.
    Koschinsky ML; Boffa MB
    Endocrinol Metab Clin North Am; 2014 Dec; 43(4):949-62. PubMed ID: 25432390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein(a), cardiovascular disease, and contemporary management.
    Jacobson TA
    Mayo Clin Proc; 2013 Nov; 88(11):1294-311. PubMed ID: 24182706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein(a) as a therapeutic target in cardiovascular disease.
    Koschinsky M; Boffa M
    Expert Opin Ther Targets; 2014 Jul; 18(7):747-57. PubMed ID: 24848373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein(a): more interesting than ever after 50 years.
    Dubé JB; Boffa MB; Hegele RA; Koschinsky ML
    Curr Opin Lipidol; 2012 Apr; 23(2):133-40. PubMed ID: 22327610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening and therapeutic management of lipoprotein(a) excess: review of the epidemiological evidence, guidelines and recommendations.
    Lippi G; Franchini M; Targher G
    Clin Chim Acta; 2011 May; 412(11-12):797-801. PubMed ID: 21256836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein(a): A missing culprit in the management of athero-thrombosis?
    Ferretti G; Bacchetti T; Johnston TP; Banach M; Pirro M; Sahebkar A
    J Cell Physiol; 2018 Apr; 233(4):2966-2981. PubMed ID: 28608522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease.
    Tsimikas S; Tsironis LD; Tselepis AD
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2094-9. PubMed ID: 17626905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models.
    Boffa MB; Marcovina SM; Koschinsky ML
    Clin Biochem; 2004 May; 37(5):333-43. PubMed ID: 15087247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New data about lipoprotein(a): a curious molecule or a causal cardiovascular risk factor?].
    de Brouckère V; Liénart F; Ducobu J
    Rev Med Brux; 2010; 31(3):171-6. PubMed ID: 20687444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein(a) in clinical practice: New perspectives from basic and translational science.
    Scipione CA; Koschinsky ML; Boffa MB
    Crit Rev Clin Lab Sci; 2018 Jan; 55(1):33-54. PubMed ID: 29262744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein(a) as a potential causal genetic risk factor of cardiovascular disease: a rationale for increased efforts to understand its pathophysiology and develop targeted therapies.
    Tsimikas S; Hall JL
    J Am Coll Cardiol; 2012 Aug; 60(8):716-21. PubMed ID: 22898069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein(a) as a marker for coronary heart disease.
    Duriez P; Dallongeville J; Fruchart JC
    Br J Clin Pract Suppl; 1994 Dec; (77):51-8. PubMed ID: 19496273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein(a) as a marker for coronary heart disease.
    Duriez P; Dallongeville J; Fruchart JC
    Br J Clin Pract Suppl; 1996 Jan; 77A():54-61. PubMed ID: 8729591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?
    Boffa MB; Koschinsky ML
    J Lipid Res; 2016 May; 57(5):745-57. PubMed ID: 26647358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein (A) in clinical practice.
    Jayasinghe R; Craig IH; Mohan RK
    J Pak Med Assoc; 2014 Apr; 64(4):447-50. PubMed ID: 24864642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on lipoprotein(a) as a cardiovascular risk factor and mediator.
    Boffa MB; Koschinsky ML
    Curr Atheroscler Rep; 2013 Oct; 15(10):360. PubMed ID: 23990263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging Therapeutic Options for Lowering of Lipoprotein(a): Implications for Prevention of Cardiovascular Disease.
    Boffa MB
    Curr Atheroscler Rep; 2016 Dec; 18(12):69. PubMed ID: 27761705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging therapeutic agents to lower lipoprotein (a) levels.
    Kolski B; Tsimikas S
    Curr Opin Lipidol; 2012 Dec; 23(6):560-8. PubMed ID: 23041907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting lipoprotein (a): an evolving therapeutic landscape.
    Man LC; Kelly E; Duffy D
    Curr Atheroscler Rep; 2015 May; 17(5):502. PubMed ID: 25736345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Genetics and the Causal Role of Lipoprotein(a) for Various Diseases.
    Kronenberg F
    Cardiovasc Drugs Ther; 2016 Feb; 30(1):87-100. PubMed ID: 26896185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.